Σύγκριση μεθόδων

	Ερωτηματολόγιο Επίγνωσης Υπογλυκαιμίας Clarke	ThyPRO
Πεδίο	Ενδοκρινολογία	Ενδοκρινολογία
Οικογένεια	Process / pipeline	Process / pipeline
Έτος προέλευσης	1995	2009
Δημιουργός	William L. Clarke, Don J. Cox, Lois A. Gonder-Frederick	Torquil Watt, Jens Bjørner, Marianne Groenvold
Τύπος	Patient self-report questionnaire	Patient self-report questionnaire
Θεμελιώδης πηγή	Clarke, W. L., Cox, D. J., Gonder-Frederick, L. A., Julian, D., Schlundt, D., & Polonsky, W. (1995). Reduced awareness of hypoglycemia in adults with IDDM: A prospective study of hypoglycemic frequency and associated symptoms. Diabetes Care, 18(6), 517-522.	Watt, T., Bjorner, J. B., Groenvold, M., et al. (2009). Establishing construct validity for the thyroid-related patient reported outcomes (ThyPRO): An initial examination. J Clin Endocrinol Metab, 94(9), 3572-3580.
Εναλλακτικές ονομασίες	HAQ, Clarke HAQ, Hypoglycemia Awareness Scale	ThyPRO-85, ThyPRO-39
Συναφείς	3	3
Σύνοψη	The Clarke Hypoglycemia Awareness Questionnaire is an 8-item instrument designed to identify patients with impaired hypoglycemia awareness—a condition in which diabetic patients fail to perceive early warning symptoms of low blood glucose, substantially increasing their risk of severe hypoglycemia. Developed by Clarke and colleagues in 1995, it is the most widely used screening tool for this dangerous complication in type 1 diabetes and in insulin-treated type 2 diabetes populations.	ThyPRO is a comprehensive patient-reported outcome measure assessing the quality of life impact of thyroid disease and its treatment across 13 dimensions. Developed by Watt and colleagues in 2009, it is the most extensively validated thyroid-specific instrument, covering both physical and psychological domains relevant to patients with hyperthyroidism, hypothyroidism, and thyroid cancer.